Colonial Trust CO / Sc Biogen Inc. Transaction History

Colonial Trust CO / Sc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $8,235 - $9,913	-37 Reduced 13.55%	236 $61,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $42,554 - $48,029	-168 Reduced 38.1%	273 $70,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $55,050 - $63,612	200 Added 82.99%	441 $125,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $60,838 - $73,919	241 New	241 $66,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

Stay updated on Colonial Trust CO / Sc with notifications on news.